Clinical Trials
99 trialsRepeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Case Comprehensive Cancer Center
I-SPY
QuantumLeap Healthcare Collaborative
AxeCan
HealthPartners Institute
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
University of Colorado, Denver
NAVIGATE
Bayer
9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
George Washington University
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Psyence Australia Pty Ltd
H3RAKLES
Institut Curie
Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer
George Washington University
LUMInova
TNC Nutrición Terapéutica S.L.
Potlako+
Brigham and Women's Hospital
AGADIR
Institut Bergonié
ATREZZO
SOLTI Breast Cancer Research Group
Proton Radiation for Stage II/III Breast Cancer
Proton Collaborative Group
A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
Duke University
ALICE
Oslo University Hospital
ICON
Oslo University Hospital
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Exelixis
Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer
CytomX Therapeutics
ALpha-T
Hoffmann-La Roche
A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer
Eisai Inc.
NSAID Effects on Clinical and Imaging Breast Biomarkers
Stony Brook University
CheckMate 7A8
Bristol-Myers Squibb
PantoCIN
University of Auckland, New Zealand
Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety
Bayer
X7-7
University of Kansas Medical Center
GW
Baylor Breast Care Center
A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer
Pfizer
Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response
NYU Langone Health
TACAC
Baylor Breast Care Center
Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
University of California, San Francisco
FINDER II
AstraZeneca
Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
Novartis
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
A Study of LY2523355 in Participants With Breast Cancer
Eli Lilly and Company
FIRST
AstraZeneca
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Masonic Cancer Center, University of Minnesota
SIGNATURE
Novartis
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
Novartis
AINO
Tampere University Hospital
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Amgen
Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer
Sinocelltech Ltd.
Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer
Puma Biotechnology, Inc.
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
Nektar Therapeutics
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Ohio State University Comprehensive Cancer Center
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
WWE
The West Clinic, Memphis
CAPRICE
SOLTI Breast Cancer Research Group